SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

A 3-year-old male pug named Nikki, with uncontrolled blood sugar levels, has started using a continuous glucose monitor (CGM) ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

A 3-year-old pug in Mumbai received a continuous glucose monitor to track his high blood sugar levels. The CGM sensor, linked ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector Read the Market Summary Here:- Global Blood Glucose Monitoring System Market is valued at approximately USD 16.46 billion in ...

A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.

The 2025 Advanced Technologies & Treatments for Diabetes (ATTD) conference took place in Amsterdam, Netherlands, bringing ...

Medicare Part B can cover a continuous glucose monitor (CGM), which offers a less invasive way of monitoring your blood sugar.

SIBIONICS participated in this prestigious event, unveiling the world's thinnest CGM device-GS3, showcasing its latest breakthrough in glucose monitoring technology. SIBIONICS GS3 Achieves CE ...

Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A ...